Interferon-α Abrogates Tolerance Induction by Human Tolerogenic Dendritic Cells

BACKGROUND: Administration of interferon-α (IFN-α) represents an approved adjuvant therapy as reported for malignancies like melanoma and several viral infections. In malignant diseases, tolerance processes are critically involved in tumor progression. In this study, the effect of IFN-α on tolerance...

Descripción completa

Detalles Bibliográficos
Autores principales: Bacher, Nicole, Graulich, Edith, Jonuleit, Helmut, Grabbe, Stephan, Steinbrink, Kerstin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144929/
https://www.ncbi.nlm.nih.gov/pubmed/21818385
http://dx.doi.org/10.1371/journal.pone.0022763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144929/
https://www.ncbi.nlm.nih.gov/pubmed/21818385
http://dx.doi.org/10.1371/journal.pone.0022763

Ejemplares similares